NetworkNewsBreaks Trxade Group, Inc. (NASDAQ: MEDS) (OTCQB: TRXD) Announces Nasdaq Uplisting, Pricing of $5.2M Firm Commitment Public Offering, Effectiveness of Reverse Stock Split
Feb 14, 2020 (MENAFN via COMTEX) —
(MENAFN – Investor Brand Network) Trxade Group (NASDAQ: MEDS) (OTCQB: TRXD) , an integrated drug procurement, delivery and healthcare platform that enables price transparency and increased profit margins to healthcare buyers and sellers of pharmaceuticals, this morning announced that its common stock will today begin trading on the Nasdaq Capital Market under the new symbol ‘MEDS’. In connection with the company’s uplisting, Trxade’s common stock will cease trading on the OTCQB. In addition, Trxade Group also announced the pricing of a firm commitment public offering of 806,452 shares of its common stock at a price to the public of $6.50 per share. Trxade Group granted a 45-day option to the underwriters to purchase up to an additional 120,967 shares of common stock to cover overallotments, if any. Trxade Group expects to secure gross proceeds of $5.2 million from the sale of common stock in the offering, which is expected to close on or about February 18, 2020, subject to customary conditions.
To view the full press release, visit http://nnw.fm/4Ix3s
About Trxade Group, Inc.
Headquartered in Tampa, Florida, Trxade Group, Inc. (NASDAQ: MEDS) is an integrated drug procurement, delivery and healthcare platform that enables price transparency and increased profit margins to healthcare buyers and sellers of pharmaceuticals. Founded in 2010, Trxade Group is comprised of three synergistic operating platforms; the Trxade B2B trading platform with 11,900 registered pharmacies, licensed virtual Wholesale and Mail Order Pharmacy delivery capabilities using DelivMeds app. For additional information, please visit www.Trxade.com .
NOTE TO INVESTORS : The latest news and updates relating to TRXD are available in the company’s newsroom at http://nnw.fm/TRXD